Newbury Pharmaceuticals AB (NEWBRY) — Defensive Interval Ratio
Newbury Pharmaceuticals AB (NEWBRY) has a Defensive Interval Ratio of 228 days as of February 2025. Defensive assets of Skr21.05 Million (cash Skr-, short-term investments Skr-, receivables Skr21.05 Million) cover 228 days of daily cash needs of Skr92.40K/day. Check NEWBRY intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Newbury Pharmaceuticals AB Defensive Interval Ratio (2021–2024)
This chart shows how Newbury Pharmaceuticals AB's Defensive Interval Ratio has evolved across 4 annual periods from 2021 to 2024. As of February 2025, the ratio stands at 228 days, meaning defensive assets of Skr21.05 Million can fund 228 days of operations without new revenue. Also explore Newbury Pharmaceuticals AB (NEWBRY) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Newbury Pharmaceuticals AB (2021–2024)
The table below presents the year-by-year Defensive Interval Ratio for Newbury Pharmaceuticals AB from 2021 to 2024, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see how much is Newbury Pharmaceuticals AB worth.
| Year | DIR (days) | Defensive Assets (SEK) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 293 days | Skr23.68 Million | Skr80.67K/day | Skr- | Skr- | ▲ +61 days |
| 2023 | 232 days | Skr7.48 Million | Skr32.24K/day | Skr- | Skr- | ▲ +150 days |
| 2022 | 82 days | Skr1.37 Million | Skr16.60K/day | Skr- | Skr- | ▼ -48 days |
| 2021 | 130 days | Skr1.54 Million | Skr11.89K/day | Skr- | Skr- | — |